In most studies, around six months of age, males of BPA-treated mothers develop insulin resistance, hyperinsulinemia, hyperleptinemia, decreased adiponectin, dyslipidemia, and decreased β-cell mass. Here, ADIPOQ is linked to Insulin resistance.